AcroViz Inc.

AcroViz develops novel imaging biomarkers for brain health, in an effort to prolong human health span and aims to end dementia with state-ofart technologies. Comprising of members who were research fellows at eminent academia and experienced industrial professionals, our team are devoted to advance scientific research, its clinical significance and application, as well as commercialization of our technologies to achieve extended impact. Our first product: AcroViz Axonal Brain Age – Brain Health Report, is the first to the market, adopting diffusion Magnetic Resonance Imaging (MRI) and Machine Learning techniques to provide accurate and objective brain health assessment, which can serve as a Mild Cognitive Impairment (MCI) marker in predicting the risk and prognosis of dementia, such as Alzheimer’s Disease (AD). AcroViz aims to end dementia with advanced neuroimaging technologies, currently working with medical or health-care institutions, and pharma or medical device companies, on various clinical trials to validate the effectiveness of intervention on MCI patients.

Read More→

Hugreen Corp.

After knowing 70 percent of humanity’s water supply goes toward growing plants, Hugreen decided to make plants production more efficient. Hugreen is a modern agriculture company that develops a solution for flower/delicate plants growers, integrating international resources to develop a precise and automated managing system. Automated facilities, irrigation, temperature controller, and lightening systems are controlled by precision agriculture sensors.
A cloud base plant library recommends the optimum conditions for different types of plants. Sensor-database cross comparison system prevents all diseases and pests beforehand by showing the alarm/recommendations to customer’s smart phone. The flexibility, accuracy and price over performance ratio let us receive more than 10000 sets preorders from Australia, north America, and Europe. Hugreen dedicate ourselves to help small farmers also can grow better and save more resources.

Read More→

Neurobit Technologies Co. Ltd.

Our mission
Neurobit is dedicated to providing a solution — A portable, wireless, eye movement/ nystagmus recording and analysis device (Neurospeed). When the medical imaging database established via artificial intelligence, we can make early detection and prediction to prevent the stroke and other brain diseases.

Company and management
Neurobit is headquartered and incorporated in Taipei City. The management of Neurobit consists of co-owners is listed below:

Travis YangCEONTU-MSE PhDBiomedical Engineering and Biomaterials Design
Roger ChenCOO & CFOFJCU-MGEMMarketing and Management
Jim HuangCTO & CDONTU-BME MSIndustrial and Mechanical Design
Ching-Fu WangTechnical ConsultantNYMU-BME PhDBiomedical Data Science Analysis

In addition, we have assembled a board of advisors to provide management expertise. The advisors are:
Tzu-Pu Chang, M.D., Department of Neurology, Johns Hopkins University School of Medicine
Ke-Hung Chien, M.D., Oculofacial plastic and Orbital surgery, Ophthalmology, UCI Health Gavin Herbert Eye Institute
Tzu-Ming Liu, Ph.D., Associate Professor, Faculty of Health Sciences, University of Macau Chun-Yi Huang, Ph.D., Former TFDA Supervisory Medical Technologist

Our services
* Rapid Screening of Stroke and Brain Diseases
* Classification of Nerve Diseases
* Pre-treatment Evaluation & Post-treatment Monitoring

Read More→

Rayark Inc.

♦ 2011.9 Rayark Inc. founded
♦ 2012 Q1 Cytus, music rhythm game, released on iOS and Android, to great acclaim
♦ 2012 Q4 Mandora, character based casual game, released on iOS and Android, 4 million downloads in 3 months
♦ 2013 Q2 & Q3 Scheduled releases of 2 new music rhythm games on mobile platforms
♦ 2013 Q4 Scheduled release of next-gen 3D action game

Rayark is a team of passionate game developers who are dedicated to creating high-quality gaming experiences on various platforms.

As a content provider, Rayark also seeks for integration of online/offline applications, such as the following events;

♦ Cytus live concert 2012 @Taipei
♦ Cytus musical 2013@Seoul
♦ Mandora collectibles pre-order
♦ Rayark artist collaboration 2013

Read More→

MobiusBobs Inc.

Knowledge is a “degree of separation” problem, and MobiusBobs aims to connect each node of knowledge, viz. people, with the edges designed to include their interpretations of a given knowledge. MobiusBobs’ mission aims to create contextually curated networks of all knowledge. The curated networks allow global citizen to better navigate around the accumulated knowledge. MobiusBobs enables the World’s innovation to be better together.

MobiusBobs creates a platform for transferring knowledge that derives tangible value from the economy. MobiusBobs is crowd knowledge exchange community that initially targets IP (Intellectual Property). While bad patents, like bad programs, are everywhere that blocking the innovation progress, MobiusBobs aims to fix it. Our clients post enquiries of IP uncertainty and globally sourced experts compete to “debug” patents for a bounty. Each contribution of “debugging” is aggregated to our knowledge base by the community of expert with diverse domain knowledge in depth.

Read More→

VMFive Inc.

VMFive is a cloud-based technology company, targeting global mobile market with its leading virtualization and streaming technologies. The premiere innovative product, AdPlay, is a cloud service that transforms mobile apps into playable ads, and enable users to try apps before downloading. In December 2014, VMFive announced collaboration with Japan’s top-three mobile advertising companies D2C and ADWAYS to introduce to Japan playable ads solution and the world’s first app pre-order platform “Yoyaku Top 10” with instant demo features. And in March 2015, VMFive announced the partnership with Trend Micro and General Mobile on Mobile World Congress. By integrating collaborators’ products and resources, VMFive has quickly established its presence in the Japanese market and is moving on to the Asia-Pacific market, actively engaging potential collaborators to create a brand new mobile advertising model.
VMFive not only earned high recommendation from customers, but also from competitions. It won the championships at TechCrunch Beijing in August 2014 and Slush Asia Tokyo in April 2015.

Read More→

LinkNext Technology Co., Ltd.

As PCs, Tablets, and Smartphone growth become saturated, LinkNext takes a first step in 2013 synergizing the data on various brands of multi-devices. By synergizing, LinkNext provides trendy designed personal gadgets enabling end users to create his own cloud with a plug-n-play approach. Simplicity, elegance, quality, and cross-platform technology are the 4 pillars supporting our product creation.

When IoTs grow to 9 billion in 2018, LinkNext will already have a platform in place to enable cross-platform and multi-device environment. Meanwhile, we have a product roadmap that will address the transformation of “legacy” things to smart IoTs.

Read More→

Gimer Medical Co. Ltd.

GiMer Medical produces electrical stimulation systems applied to pain relief of chronic back pain, cancer and carpal tunnel syndrome. Founded in 2013, the company is commercializing novel biomedical engineering research from the National Taiwan University (NTUon the animal responses to electrical stimulation of various parameter. The premier product, GiMer Neuroblock, is an implantable Spinal Cord Stimulation (SCS) system for the chronic pain management market and the first SCS therapy system developed in Asia. Back pain is one of the most common ailments, next to the common cold. The current SCS market is estimated at $2B globally, and projected to grow significantly with the aging population and significant adoption in Asia. GiMer Medical is one of the top medical device start-ups in Taiwan, and has been awarded the rookie award at the Taiwan Biomedical Show and National Innovation Award for Outstanding Academic Research Spinout. In 2014, its space also was approved as a production facilitye, becoming Taiwan’s first implantable devices facility. The company is positioned to become the leader of Taiwan’s implantable devices market and will lead Asia into the era of neuromodulation treatment.

Read More→